Bring your vision to life.

Capital with vision

capiton enables small and medium-sized businesses in the DACH region to achieve ambitious goals. Not only do they receive capital from us, they also benefit from our expertise and personal support. We listen carefully, make quick decisions and are accessible, because we know that nothing generates confidence like your own vision in your own hands.

Finance

News

CNP Group

The company

CNP Group (“CNP”) is an international manufacturer and distributor of generic pharmaceuticals with a focus on anti-infectives. In addition to antibiotics, CNP offers over-the-counter medicines and medical devices. Most of the products are manufactured at the company’s two production sites in Saarland, Germany. CNP owns marketing authorizations for approx. 400 pharmaceutical products and generates revenues of more than € 40 million with approx. 250 employees. The group is active in 19 countries.

 

In cooperation with the management team and supported by industry experts, capiton plans to leverage the company’s substantial local production capacity and international footprint to further strengthen CNP´s leading position in target niche markets.

 

The transaction

capiton acquired CNP Group from the founding family together with the management team as well as senior industry experts. Financing of the transaction is provided by capiton’s current investment vehicle, capiton VI. Additional funds have been reserved to finance both organic and inorganic growth initiatives in Germany and abroad.

 

The transaction remains subject to approval from competition authorities. Sellers and buyers have agreed not to disclose the financial terms of the transaction.

capiton was advised by Hampton Pharma and Fidelio Healthcare Partners (Commercial), PwC (Financial), EY (Tax), BMH (Legal), Straeter Rechtsanwaelte (Pharma law), Dr. Regenold GmbH (Regulatory and technical due diligence), Willis Tower Watson (Insurance), AvS (Management audit) and Tauw (ESG & EDD).

Facts & Figures

Foundation

capiton’s predecessor company was founded in the mid-1980s. capiton AG was established in 1999. The firm became an independent company in 2004, following a Management-Buy-Out.

Partnership

capiton is managed by 9 partners and is an owner-managed financial investor.

Track record

The capiton team has supported more than 80 companies, and over 70 investments have been realised. At present, the company manages a fund volume of €1.1 billion.

Investment range

capiton invests in small and medium-sized companies in German-speaking countries. We usually invest between €20 and €60 million of our own funds in profitable companies with turnover between €50 and €300 million. We are also able to execute much larger transactions together with co-investors.

What our portfolio companies say

capiton is familiar with the needs of SMEs, understands them, and acts accordingly.

Josef Raith, Founder
RTS